Back to company

Renescience A/S: Financial statements 2020

CVR: 31846803

Renescience A/S (CVR 31846803) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 1,692,000 and a net result of DKK -13,492,000 compared with DKK -18,126,000 the year before. The profit margin was -797.4%. Equity amounted to DKK 31,076,000. The solvency ratio was 89.3%.

Revenue
1,692,000 kr.
Gross Profit
-16,589,000 kr.
Profit/Loss
-13,492,000 kr.
Equity
31,076,000 kr.
Total Assets
34,789,000 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20201.7 mio.-16.6 mio.-13.5 mio.31.1 mio.-
2019--23.2 mio.-18.1 mio.44.6 mio.-
2018--24.3 mio.-19.1 mio.62.7 mio.-
2017--9.7 mio.-7.8 mio.81.8 mio.-
2016--37.1 mio.-29.5 mio.89.5 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Renescience A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Renescience A/S: The 2019 annual report is outMay 15, 2020

Renescience A/S has published its annual report for 2019. Gross profit came to DKK -23,169,000, and the net result was DKK -18,126,000.

About Renescience A/S

Renescience A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Holm Lerke-Møller. The company is owned by Ørsted New Bio Solutions Holding A/S. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. Equity amounted to DKK 73,470,000.